Nesfatin-1 protects against diabetic cardiomyopathy in the streptozotocin-induced diabetic mouse model via the p38-MAPK pathway

Nesfatin-1 is a novel anorexigenic peptide that possesses antihyperglycemic and cardiovascular effects. We hypothesized that nesfatin-1 has a beneficial protective effect against diabetic cardiomyopathy (DC). We investigated the therapeutic effect of nesfatin-1 on diabetes-associated cardiac dysfunc...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Zhanwei, Dong, Jianjiang, Mu, Yindong, Liu, Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342195/
https://www.ncbi.nlm.nih.gov/pubmed/35818327
http://dx.doi.org/10.1080/21655979.2022.2066748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342195/
https://www.ncbi.nlm.nih.gov/pubmed/35818327
http://dx.doi.org/10.1080/21655979.2022.2066748

Ejemplares similares